Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Akanksha Bakshi

RBC Capital Raises Dialogue Health Technologies Price Target, Positive On Recent Acquisition

  • RBC Capital analyst Douglas Miehm raised the price target for Dialogue Health Technologies Inc (TSX:CARE) to C$10 from C$9 with the Sector Perform rating on the shares.
  • Last week CARE announced the acquisition of London, U.K.-based Tictrac Ltd. for up to C$56 million (5.3x 2022E revenues). Tictrac is a SaaS-based provider of a global health and wellness platform that enables healthier living for everyone.
  • Miehm views the Tictrac acquisition positively, as it strengthens Dialogue’s value proposition as a fully integrated digital health platform.
  • Price Action: CARE shares are trading higher by 1.52% at C$6.00 on TSX on the last check Monday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.